A detailed history of Atria Investments LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Atria Investments LLC holds 3,330 shares of HAE stock, worth $204,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,330
Previous 3,221 3.38%
Holding current value
$204,162
Previous $258,000 0.78%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$71.16 - $93.38 $7,756 - $10,178
109 Added 3.38%
3,330 $260,000
Q3 2024

Nov 01, 2024

SELL
$72.45 - $91.58 $71,797 - $90,755
-991 Reduced 23.53%
3,221 $258,000
Q2 2024

Aug 13, 2024

BUY
$81.24 - $97.37 $342,182 - $410,122
4,212 New
4,212 $348,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.15B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.